These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33242090)

  • 1. Ligand-Dependent Effects of Methionine-8 Oxidation in Parathyroid Hormone Peptide Analogues.
    Daley EJ; Khatri A; Dean T; Vilardaga JP; Zaidi SA; Katritch V; Gardella TJ
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33242090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor.
    Carter PH; Dean T; Bhayana B; Khatri A; Rajur R; Gardella TJ
    Mol Endocrinol; 2015 Feb; 29(2):307-21. PubMed ID: 25584411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.
    Li M; Hasan AA; Chu C; Hocher JG; Liu Y; Zhang X; Chen X; Yard B; Krämer BK; Hocher B
    Pflugers Arch; 2024 Jun; 476(6):889-899. PubMed ID: 38393416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Activity of Different Forms of Oxidized Parathyroid Hormone.
    Hasan AA; Hocher CF; Kleuser B; Krämer BK; Hocher B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights into peptide agonist engagement with the PTH receptor.
    Cary BP; Gerrard EJ; Belousoff MJ; Fletcher MM; Jiang Y; Russell IC; Piper SJ; Wootten D; Sexton PM
    Structure; 2023 Jun; 31(6):668-676.e5. PubMed ID: 37148874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys.
    Shimizu M; Joyashiki E; Noda H; Watanabe T; Okazaki M; Nagayasu M; Adachi K; Tamura T; Potts JT; Gardella TJ; Kawabe Y
    J Bone Miner Res; 2016 Jul; 31(7):1405-12. PubMed ID: 26865415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphtheria Toxin- and GFP-Based Mouse Models of Acquired Hypoparathyroidism and Treatment With a Long-Acting Parathyroid Hormone Analog.
    Bi R; Fan Y; Lauter K; Hu J; Watanabe T; Cradock J; Yuan Q; Gardella T; Mannstadt M
    J Bone Miner Res; 2016 May; 31(5):975-84. PubMed ID: 26678919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism.
    Krishnan V; Ma YL; Chen CZ; Thorne N; Bullock H; Tawa G; Javella-Cauley C; Chu S; Li W; Kohn W; Adrian MD; Benson C; Liu L; Sato M; Zheng W; Pilon AM; Yang NN; Bryant HU
    Br J Pharmacol; 2018 Jan; 175(2):262-271. PubMed ID: 28898923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH.
    Maeda A; Okazaki M; Baron DM; Dean T; Khatri A; Mahon M; Segawa H; Abou-Samra AB; Jüppner H; Bloch KD; Potts JT; Gardella TJ
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5864-9. PubMed ID: 23533279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
    Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
    ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism.
    Tamura T; Noda H; Joyashiki E; Hoshino M; Watanabe T; Kinosaki M; Nishimura Y; Esaki T; Ogawa K; Miyake T; Arai S; Shimizu M; Kitamura H; Sato H; Kawabe Y
    Nat Commun; 2016 Nov; 7():13384. PubMed ID: 27857062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment.
    Guo J; Khatri A; Maeda A; Potts JT; Jüppner H; Gardella TJ
    J Bone Miner Res; 2017 Jan; 32(1):86-98. PubMed ID: 27428040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.
    Tay D; Cremers S; Bilezikian JP
    Br J Clin Pharmacol; 2018 Feb; 84(2):252-267. PubMed ID: 29049872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A salt bridge between Arg-20 on parathyroid hormone (PTH) and Asp-137 on the PTH1 receptor is essential for full affinity.
    Weaver RE; Wigglesworth MJ; Donnelly D
    Peptides; 2014 Nov; 61():83-7. PubMed ID: 25218037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mid-region of parathyroid hormone (1-34) serves as a functional docking domain in receptor activation.
    Wittelsberger A; Corich M; Thomas BE; Lee BK; Barazza A; Czodrowski P; Mierke DF; Chorev M; Rosenblatt M
    Biochemistry; 2006 Feb; 45(7):2027-34. PubMed ID: 16475791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
    Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
    Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
    Goold CP; Usdin TB; Hoare SR
    J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe.
    Carter PH; Liu RQ; Foster WR; Tamasi JA; Tebben AJ; Favata M; Staal A; Cvijic ME; French MH; Dell V; Apanovitch D; Lei M; Zhao Q; Cunningham M; Decicco CP; Trzaskos JM; Feyen JH
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6846-51. PubMed ID: 17428923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
    van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
    Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.